Robert Matthew Lutz, CFO at Strongbridge Biopharma, holds 400.00K shares in Savara (Ticker: SVRA), holds 102.17K shares in Ibio (Ticker: IBIO), holds 181.33K shares in Strongbridge Biopharma (Ticker: SBBP).

See the Hottest Stocks Based on Insider Trading >

Robert Matthew Lutz
Strongbridge Biopharma (SBBP)
CFO

Not Ranked

Robert Matthew Lutz has not reported sufficient informative transactions and therefore cannot be ranked.

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

77.93%

SVRA

22.07%

IBIO

A breakdown of Robert Matthew Lutz's holdings

See the Top Stocks by Insiders

Insider Roles

Savara
(SVRA)

COO

Ibio
(IBIO)

Chief Financial & Business Officer and Principal Accounting Officer

Roles that Robert Matthew Lutz holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Ibio
(IBIO)

Rating:Informative Sell

Date:Mar 14, 2022 - Mar 14, 2023

Return:+79.20%

The most profitable trade made by Robert Matthew Lutz

See the Latest Stocks Traded by Insiders

Robert Matthew Lutz's Trading History

SBBP

Strongbridge Biopharma

Feb 23, 2021

―

Uninformative Sell

25.26K

$362.67K

IBIO

Ibio

Nov 15, 2022

Chief Financial & Business Officer and Principal Accounting Officer

Uninformative Buy

―

$302.41K

SVRA

Savara

Dec 16, 2024

COO

Uninformative Buy

―

$1.07M

List of latest transactions for each holding click on a transaction to see Robert Matthew Lutz's performance on stock

See All Insider Trading from Today

Robert Matthew Lutz insider profile FAQ

What is the percentage of profitable transactions made by Robert Matthew Lutz?

The percentage of profitable transactions made by Robert Matthew Lutz is ―.

What is the average return per transaction made by Robert Matthew Lutz?

The average return per transaction made by Robert Matthew Lutz is ―.

What stocks does Robert Matthew Lutz hold?

Robert Matthew Lutz holds: SBBP, IBIO, SVRA stocks.

What was Robert Matthew Lutz’s latest transaction?

Robert Matthew Lutz latest transaction was an Uninformative Buy of ―.

What was Robert Matthew Lutz's most profitable transaction?

Robert Matthew Lutz’s most profitable transaction was an Informative Sell of IBIO stock on March 14, 2022. The return on the trade was 79.20%.

What is Robert Matthew Lutz's role in Strongbridge Biopharma?

Robert Matthew Lutz's role in Strongbridge Biopharma is CFO.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Robert Matthew Lutz Insider Profile

Robert Matthew Lutz Strongbridge Biopharma (SBBP)CFO